Psoriasis rheumatism, or psoriatic arthritis as it is medically known, is an inflammatory rheumatism that affects 7-40% of psoriasis patients. As the name suggests, the disease is seen in psoriasis patients. However, not every psoriasis patient has psoriasis rheumatism.
Rheumatic findings appear after psoriasis in the majority of patients. However, in a smaller proportion, psoriasis findings appear at the same time as psoriasis or after joint findings.
Psoriasis rheumatism can occur alone in the hand joints as well as in the knee joint. In some patients, the disease progresses alone with waist and hip pain and morning stiffness. In fact, the complaint of morning stiffness, which is one of the most important findings of rheumatic diseases, is also one of the important findings of psoriasis rheumatism.
Psoriasis is often accompanied by pin-like holes in the nails, called pitting. In addition, separation from the nail bed in the form of yellowing of the nails may also be accompanied.
There is no clear relationship between the disorganization or abundance of psoriasis wounds and the severity of psoriasis. In other words, a patient may have severe joint symptoms even though he/she has a single psoriasis lesion, and may not have any joint complaints even though he/she has psoriasis lesions all over his body.
The genetic transmission of psoriasis is very high. Therefore, the presence of psoriasis in one person in the family is an important sign that psoriasis may also occur in other people.
The question "Is there a blood test that can diagnose psoriasis is frequently asked?" Especially when joint symptoms are severe, inflammation tests in the blood may increase. Apart from this, the diagnosis is made according to the clinical condition of the patient. There is no specific blood test for the disease.
Treatment of the disease depends entirely on the severity of the disease. Medications such as methotrexate are often first choice medications. Apart from this, biological therapies can be considered as alternative treatments in patients who do not respond to this drug or treatment. It is very difficult to comment on the duration of treatment because each patient's condition varies. Many It is usually appropriate to review the treatment again after a 2-year treatment period.
The biggest advantage of the drugs given for psoriasis rheumatism is that they are effective on both psoriasis lesions and psoriasis rheumatism.
Read: 0
